Tenenbaum Fabian Insider Trades

Insider Trading History

Track insider trading activity for Tenenbaum Fabian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $4.89k 407,459 shares
Last Trade
Nov 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$392k 76,823 shares
$5.10
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $65.3k 5,440,697 shares
Last Trade
Sep 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.1M 1,752,000 shares
$7.50
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $5.81k 484,282 shares
Last Trade
May 21, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.5k 5,000 shares
$9.30
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $44.3k 3,688,697 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 12,500 shares
$13.20
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $44.1k 3,676,197 shares
Last Trade
Nov 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.3M 1,487,500 shares
$13.65
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $5.75k 479,282 shares
Last Trade
Sep 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.6M 224,299 shares
$16.05
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $3.06k 254,983 shares
Last Trade
Jun 12, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.24M 63,486 shares
$35.25
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $6.6k 550,000 shares
Last Trade
Jan 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.4M 605,419 shares
$30.45
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $3.16k 263,050 shares
Last Trade
Mar 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67M 120,193 shares
$22.20
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $12.5k 1,042,556 shares
Last Trade
Dec 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.66M 1,042,556 shares
$7.35
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $1.71k 142,857 shares
Last Trade
Nov 29, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.06M 285,714 shares
$7.20
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Chief Executive Officer
Holding Value $5.59k 466,141 shares
Last Trade
Nov 11, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.85M 466,141 shares
$14.70
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
CFO & Chief Business Officer
Holding Value $1.56k 130,000 shares
Last Trade
Feb 29, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.49M 130,000 shares
$34.50
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up